Adaptive Biotechnologies Corp Working Capital to Net Assets Ratio
Adaptive Biotechnologies Corp working capital to net assets ratio. Adaptive Biotechnologies Corp (ADPT) has a Working Capital to Net Assets ratio of 93.5% as of December 2025. Working capital of $210.27 Million (current assets of $300.19 Million minus current liabilities of $89.92 Million) is measured against net assets of $225.00 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. Check ADPT tangible net assets ratio to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Adaptive Biotechnologies Corp (2017–2025)
Working capital to net assets ratio of Adaptive Biotechnologies Corp from 2017 to 2025. This chart shows how Adaptive Biotechnologies Corp's Working Capital to Net Assets ratio has evolved across 9 annual periods from 2017 to 2025. As of December 2025, the ratio stands at 93.5%, reflecting working capital of $210.27 Million against net assets of $225.00 Million USD. See Adaptive Biotechnologies Corp defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.
Adaptive Biotechnologies Corp Working Capital to Net Assets Ratio by Year (2017–2025)
Adaptive Biotechnologies Corp working capital to net assets ratio by year from 2017 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for Adaptive Biotechnologies Corp from 2017 to 2025, covering 9 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see balance sheet size of Adaptive Biotechnologies Corp.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 93.5% | $210.27 Million | $225.00 Million | $300.19 Million | $89.92 Million | ▲ +1.7 pp |
| 2024 | 91.7% | $185.70 Million | $202.49 Million | $283.75 Million | $98.05 Million | ▼ -12.8 pp |
| 2023 | 104.5% | $322.17 Million | $308.28 Million | $410.19 Million | $88.02 Million | ▲ +7.0 pp |
| 2022 | 97.5% | $452.36 Million | $464.10 Million | $562.15 Million | $109.79 Million | ▲ +49.6 pp |
| 2021 | 47.8% | $288.94 Million | $604.10 Million | $402.75 Million | $113.81 Million | ▼ -35.8 pp |
| 2020 | 83.6% | $621.72 Million | $743.27 Million | $726.91 Million | $105.20 Million | ▼ -9.9 pp |
| 2019 | 93.6% | $534.38 Million | $571.04 Million | $612.69 Million | $78.31 Million | ▲ +154.8 pp |
| 2018 | -61.2% | $157.92 Million | $-258.11 Million | $180.72 Million | $22.80 Million | ▲ +20.8 pp |
| 2017 | -82.0% | $184.24 Million | $-224.62 Million | $205.25 Million | $21.00 Million | — |